Welcome to the 7th CNS Drug Delivery Summit
Despite milestones such as Roche’s Trontinemab Brainshuttle™ achieving robust amyloid clearance, challenges remain in reaching targeted brain regions, improving predictive modelling, ensuring efficacy and penetrance, and developing safer, targeted delivery approaches.
Join 100+ industry experts spanning neuroscientists, chemists, device engineers, conjugation scientists, DMPK experts, delivery specialists, and more at the 7th CNS Drug Delivery Summit to collaborate, network, and learn cutting-edge strategies that are tackling the unique challenges in gaining access to the brain.
Gain actionable insights from case studies, presentations, and deep-dive discussions on CNS drug delivery strategies covering systemic and local delivery, blood-brain barrier targeting, RMT modulation, and emerging modalities from Biogen, Sanofi, Merck, UCB, Eli Lilly, Alnylam, Voyager, and more, to advance brain access and accelerate CNS therapy development.
View the Full Event Guide:
World-Class Speaker Faculty Includes:
Lisa Shafer
Vice President, Product Development & Regulatory CMC, Medical Devices & Packaging
Biogen
Previously Attending Companies Include
Top Testimonials:
The smooth organization and impressive line-up of speakers made the experience enjoyable, offering valuable insights and engaging sessions.
Alchemab Therapeutics Ltd
The sharing of information and perspectives between the wide array of experts in the room. We had neurosurgeons, engineers, chemists, biologists, formulation experts and others all around 1table communicating.
Biogen
Our Partners:
Other Events in the CNS Series:
